Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
Has announcements
×
Carcinoma, Transitional Cell
×
Clear all
Filters
3
NCT03219333
2024-08-27
EV-201
Astellas Pharma Inc
Phase 2
Completed
219 enrolled
32 charts
2 FDA
NCT02603432
2024-03-27
JAVELIN Bladder 100
Pfizer
Phase 3
Completed
700 enrolled
35 charts
2 FDA
NCT02793128
2020-12-22
Olympus
UroGen Pharma Ltd.
Phase 3
Completed
71 enrolled
16 charts
2 FDA